Skip to content

The Effectiveness of Laparoscopic Treatment of Superficial Endometriosis for Managing Chronic Pelvic Pain

The Effectiveness of Laparoscopic Treatment of Isolated Superficial Peritoneal Endometriosis for Managing Chronic Pelvic Pain in Women: a Randomised Controlled Feasibility Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04081532
Acronym
ESPriT1
Enrollment
7
Registered
2019-09-09
Start date
2019-09-30
Completion date
2021-04-01
Last updated
2024-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis, Pelvic Pain

Keywords

endometriosis, laparoscopy, pelvic pain

Brief summary

Endometriosis is a chronic, incurable condition that affects about 10% of women of reproductive age. It is defined as a growth of cells similar to the womb lining outside of the womb in the pelvis, and is associated with chronic pelvic pain, excessive period pain, pain with sexual intercourse and difficulties in getting pregnant. If the disease is found only on the lining of the pelvis it is known as superficial peritoneal and is usually treated during a laparoscopic surgery by cutting out (excision) or burning off (ablation). However, many women do not find improvement in their symptoms after the surgery and can have complications from the procedure. The aim of this study is to determine if removal of the superficial peritoneal endometriosis improves pain symptoms and quality of life, which method of removal (excision or ablation) is more effective or if surgical removal is of no benefit to the patients and can potentially cause harm. The investigators plan to recruit up to 90 women from four NHS hospitals in Scotland over a period of 12 months. Women who are attending gynaecology departments with pelvic pain who have not previously had a diagnosis of endometriosis via laparoscopy will be approached. Patients will be asked to read an information sheet about the trial. Women who consent to the trial will be randomised during the surgery, if superficial endometriosis is found, to either having the endometriosis removed or not. For this pilot, follow up will be at 3 and 6 months (and obtain permission to continue to follow them up at 12 and 24 months should time and finding permit). Patients who do not consent to take part in the trial will be asked if the investigators can collect data on their demographics and reasons on why they did not wish to take part.

Interventions

PROCEDUREsurgical removal of superficial peritoneal endometriosis

In the active comparator group patients will have endometriosis lesions removed by ablation or excision. Patients randomised to no surgical treatment arm will not have lesions removed and will only be given diagnosis on whether endometriosis was found or not.

Sponsors

NHS Grampian
CollaboratorOTHER_GOV
University of Nottingham
CollaboratorOTHER
University of Edinburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Masking description

General Practitioner

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Undergoing laparoscopy for the investigation of chronic pelvic pain * In order to be randomised, isolated superficial peritoneal endometriosis (SPE) must be identified at laparoscopy (macroscopically) * Able to give informed consent

Exclusion criteria

* Previous surgical diagnosis of endometriosis * Pregnant or are actively trying for pregnancy within the next six months * Deep endometriosis or ovarian endometrioma on imaging or at laparoscopy * Peritoneal 'pockets' only noted at laparoscopy

Design outcomes

Primary

MeasureTime frameDescription
Proportion of women with suspected SPE undergoing diagnostic laparoscopy that were approached for the study an agreed to randomisationScreeningThe proportion of screened women who are eligible for the trial determined from the screening logs

Secondary

MeasureTime frameDescription
Proportion of women having laparoscopy for investigation of chronic pelvic pain that are eligible (i.e. have only SPE) for the trialvisit 2 (day of surgery)The proportion of women undergoing diagnostic laparoscopy who go on to be diagnosed with SPE
Effects of treatment and variability in treatment outcomesvisit 2 (day of surgery), 30 days post surgeryIntraoperative and postoperative complications
Improvement in quality of life30 days post surgery, follow up at 3 and 6 monthsEndometriosis Health Profile-30 (EHP-30)
Baseline characteristics of eligible women that agree to be randomised and those that decline participationScreeningBaseline characteristics including age, social deprivation, ethnicity and duration of pain collected from screened women
To determine the most acceptable methods of assessment toolsThroughout the trial until end of follow up at 6 monthsNumber of patients who remained blinded for 6 months after the surgery recorded by asking patient if they were told their allocation
To determine the most acceptable methods of recruitment, randomisation and assessment tools6 months follow upAcceptability of the trial completed at 6 months after surgery will be compared between two arms.
To determine the most acceptable methods of recruitment and assessment toolsQuestionnaires collected at Baseline (within a week of surgery), 3 and 6 months follow upThe proportion of completed trial questionnaires

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026